Cartesian Therapeutics
RNAC
RNAC
38 hedge funds and large institutions have $95M invested in Cartesian Therapeutics in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
Holders
38
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$12.5M | |
| 2 | +$10.9M | |
| 3 | +$7.82M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$7.82M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$5.34M |
Top Sellers
| 1 | -$6.6M | |
| 2 | -$942K | |
| 3 | -$378K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$166K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$54.5K |